Medical Services

 A collection of hereditary genetic conditions marked by increasing weakening and loss of skeletal muscle mass is known as muscular dystrophy (MD).  Affected muscles weaken over time and could atrophy, greatly limiting daily tasks and physical activity.

There are various forms of muscular dystrophy; among them are Duchenne and Becker's most often occurring forms. Usually starting in early life, Duchenne muscular dystrophy advances quickly; Becker moves more slowly and shows later. Other conditions, including limb-girdle, facioscapulohumeral, and myotonic dystrophy, differ in age of start, symptoms, and degree of severity.
Though there isn't a treatment for muscular dystrophy right now, medical advancements have raised life expectancy and standard of living. Offering optimism for more efficient future treatments, genetic research keeps investigating new therapeutics like gene editing and stem cell treatment.
Management of symptoms, slow progression, and enhancement of results all depend on early diagnosis. For as long as patients can, regular monitoring and a multidisciplinary approach to treatment enable them to keep mobility and independence. Although muscular dystrophy is still a difficult disorder, continuous research keeps stretching the boundaries of available therapy approaches.